Combination Chemotherapy Using Intravenous Nedaplatin (254-S) and Intraarterial Cisplatin (CDDP) With Transcatheter Arterial Embolization (TAE) for a Patient With Uterine Cervical Cancer: A Case Report

S. Adachi, N. Yamasaki, T. Ogasawara, Y. Takayasu, T. Takemura, K. Koyama
1997 Japanese Journal of Clinical Oncology  
A 45-year-old Japanese woman with a bulky (75 × 40 mm) stage 2a uterine cervical cancer was treated with 87 mg (50 mg/m 2 ) of nedaplatin (254-S) intravenously and 120 mg (70 mg/m 2 ) of cisplatin (CDDP) intraarterially with transcatheter arterial embolization (TAE). She received three courses of this combination chemotherapy and showed a complete response, as confirmed by magnetic resonance imaging. A radical hysterectomy was performed and the pathological findings revealed the absence of
more » ... the absence of carcinoma cells. This type of combination chemotherapy seems to be effective for the treatment of locally advanced uterine cervical cancer.
doi:10.1093/jjco/27.6.442 pmid:9438011 fatcat:vtfpx3ulbbauzgfop5xqqticgy